ROCKET PHARMACEUTICALS, INC. WARRANT reports a Return on Equity (ROE) of -87.96%.

What is RCKTW's dividend yield?

ROCKET PHARMACEUTICALS, INC. WARRANT offers a dividend yield of 0.00%.

What is RCKTW's Deepscope Quality Score?

Deepscope rates RCKTW's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RCKTW?

Deepscope's AI Timing Score for RCKTW is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RCKTW belong to?

ROCKET PHARMACEUTICALS, INC. WARRANT is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

RCKTW (NASDAQ) Stock Analysis | ROCKET PHARMACEUTICALS, INC. WARRANT

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-11 | FS: 2026-03-31)

RCKTW

ROCKET PHARMACEUTICALS, INC. WARRANT

US:NASDAQ STOCK Healthcare >> Biotechnology News 81

USD 0.01

-0.00 (-1.03%) Day Change

Watchlist Portfolio Compare Chart

0.20

D/E

-88.0%

ROE

-73.4%

ROA

0.00%

Div Yield

ROCKET PHARMACEUTICALS, INC. WARRANT
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.01 Price -0.00 (-1.03%) Day Change	NEWS SCORE: 81

RCKTW, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	81
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.01
PBV / Sector	N/A / 4.79
Earning Per Share	N/A

PE / Sector	N/A / 18.05
PEG or PE/Growth / Sector	N/A / 0.62
Average 1M Daily Value	105.645400000000
Average 1W Daily Value	113.286340000000

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-73.36 / 31.69
ROA Average (%) / Sector	-54.70 / -353.18
ROA Change Average (%) / Sector	16.82 / 5,214.65 GOOD
ROE (%) / Sector	-87.96 / 10.58
ROE Average (%) / Sector	-63.89 / 27.64
ROE Change Average (%) / Sector	18.86 / 2,048.88 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Registration Details

Analyze Date	2026-06-12 09:43:52
Symbol	RCKTW
Name	ROCKET PHARMACEUTICALS, INC. WARRANT
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / 9,010.81

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: -

Phone: -

Website: -

Employees: 240

Sector: Healthcare >> Biotechnology

Description: Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.